Pathophysiology

Citations 361-370 of 1277 total displayed.

Past content (since Jan 1999):

Articles
Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation: E. Lutgens, S. P.M. Lutgens, B. C.G. Faber, S. Heeneman, M. M.J. Gijbels, M. P.J. de Winther, P. Frederik, I. van der Made, A. Daugherty, A. M. Sijbers, A. Fisher, C. J. Long, P. Saftig, D. Black, M. J.A.P. Daemen, and K. B.J.M. Cleutjens
Circulation published December 19, 2005, doi:10.1161/CIRCULATIONAHA.105.561449 [Abstract]

Special Reports
Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses: Pascal J. Goldschmidt-Clermont, Mark A. Creager, Douglas W. Lorsordo, Gregory K.W. Lam, Momtaz Wassef, and Victor J. Dzau
Circulation 2005;112:3348-3353, doi:10.1161/CIRCULATIONAHA.105.577460 [Full text]

Epidemiology
Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study: Ann Smith, Chris Patterson, John Yarnell, Ann Rumley, Yoav Ben-Shlomo, and Gordon Lowe
Circulation 2005;112:3080-3087, doi:10.1161/CIRCULATIONAHA.105.557132 [Abstract] [Full text]

Vascular Medicine
The Thromboxane A₂ Receptor Antagonist S18886 Prevents Enhanced Atherogenesis Caused by Diabetes Mellitus: Adriana Zuccollo, Chaomei Shi, Roberto Mastroianni, Karlene A. Maitland-Toolan, Robert M. Weisbrod, Mengwei Zang, Shanqin Xu, Bingbing Jiang, Jennifer M. Oliver-Krasinski, Antonio J. Cayatte, Stefano Corda, Gilbert Lavielle, Tony J. Verbeuren, and Richard A. Cohen
Circulation 2005;112:3001-3008; published online before print as doi:10.1161/CIRCULATIONAHA.105.581892 [Abstract] [Full text]

Vascular Medicine
Involvement of Thromboxane Receptor in the Proatherogenic Effect of Isoprostane F₂-III: Evidence From Apolipoprotein E– and LDL Receptor–Deficient Mice: Myan Tang, Tillmann Cyrus, Yuemang Yao, Luigina Vocun, and Domenico Praticò
Circulation 2005;112:2867-2874, doi:10.1161/CIRCULATIONAHA105.562223 [Abstract] [Full text]

Vascular Medicine
Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice: Olivier Phan, Ognen Ivanovski, Thao Nguyen-Khoa, Nadya Mothu, Jesus Angulo, Ralf Westenfeld, Markus Ketteler, Natalie Meert, Julien Maizel, Igor G. Nikolov, Raymond Vanholder, Bernard Lacour, Tilman B. Drüeke, and Ziad A. Massy
Circulation 2005;112:2875-2882, doi:10.1161/CIRCULATIONAHA105.541854 [Abstract] [Full text]

Articles
The Thromboxane A₂ Receptor Antagonist S18886 Prevents Enhanced Atherogenesis Caused by Diabetes Mellitus: Adriana Zuccollo, Chaomei Shi, Roberto Mastroianni, Karlene A. Maitland-Toolan, Robert M. Weisbrod, Mengwei Zang, Shanqin Xu, Bingbing Jiang, Jennifer M. Oliver-Krasinski, Antonio J. Cayatte, Stefano Corda, Gilbert Lavielle, Tony J. Verbeuren, and Richard A. Cohen
Circulation published October 31, 2005, doi:10.1161/CIRCULATIONAHA.105.581892 [Abstract]

Editorials
Oxidative Stress and the Vascular Wall: NADPH Oxidases Take Center Stage: John F. Keaney, Jr
Circulation 2005;112:2585-2588, doi:10.1161/CIRCULATIONAHA.105.578146 [Full text]

Heart Failure
Selective Activation of Inflammatory Pathways by Intermittent Hypoxia in Obstructive Sleep Apnea Syndrome: Silke Ryan, Cormac T. Taylor, and Walter T. McNicholas
Circulation 2005;112:2660-2667, doi:10.1161/CIRCULATIONAHA.105.556746 [Abstract] [Full text]

Vascular Medicine
Matrix Metalloproteinase-13/Collagenase-3 Deletion Promotes Collagen Accumulation and Organization in Mouse Atherosclerotic Plaques: Jun-O Deguchi, Elena Aikawa, Peter Libby, Jeffrey R. Vachon, Masaki Inada, Stephen M. Krane, Peter Whittaker, and Masanori Aikawa
Circulation 2005;112:2708-2715; published online before print as doi:10.1161/CIRCULATIONAHA.105.562041 [Abstract] [Full text]

Subspecialty Collections Home

Show Pathophysiology
collections from other journals.

Related collections:
Atherosclerosis
Pathophysiology
Risk Factors
Other arteriosclerosis